Advertisement

Antonie van Leeuwenhoek

, Volume 17, Issue 1, pp 183–188 | Cite as

Studies on haemagglutination by the EMC-MM-Columbia SK-group of viruses

IV. Experiments with egg-adapted virus
  • J. D. Verlinde
  • P. Waller-Fetter
  • P. de Baan
Article

Summary

When MM and Columbia SK virus were propagated in the chick embryo, the virus disappeared from the allantoic fluid and from the embryonic brain tissue after 6 to 9 chorioallantoic passages. Amniotic passages, however, resulted in a gradual increase of the mouse infectivity titre of the amniotic fluid and of the fluid of the regularly observed subcutaneous edema of the embryos, though after 22 passages the ID50 titre was still 3 logs lower than that of the original mouse brain suspension. The virus was present not only in amniotic fluid, but also in allantoic fluid and throughout the whole embryo. In spite of the pretty high mouse infectivity titres, the extra-embryonic fluids failed to produce haemagglutination of sheep red cells, whereas low haemagglutination titres could be obtained with suspensions of embryonic brain tissue. No evidence was obtained, that a non-specific inhibitor was responsible for the inability to produce haemagglutination. The virus present in egg fluids is only partially adsorbed, which is in contrast with the almost complete adsorption of virus in mouse brain suspension. The adsorption of a relatively small amount of virus might be one of the factors responsible for lack of haemagglutinating ability. It is suggested, that another coinciding factor, which is necessary for the initiation of the haemagglutination might be present in the central nervous system lesion.

Keywords

Central Nervous System Gradual Increase Amniotic Fluid Chick Embryo Allantoic Fluid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    P.de Baan, Verhandelingen Inst. v. Praev. GenceskundeXVII, 1950.Google Scholar
  2. 2.
    P. de Baan, J. D. Verlinde andP. Waller-Fetter, Antonie van Leeuwenhoek17, 119, 1951.PubMedGoogle Scholar
  3. 3.
    A. Bremer, Ann. Inst. Pasteur80, 40, 1951.Google Scholar
  4. 4.
    P. Brutsaert, C. W. Jungeblut andA. Knox, Journ. Pediatr.29, 350, 1946.Google Scholar
  5. 5.
    J. B. Enright andH. W. Schultz, Proc. Soc. exp. Biol. a. Med.66, 541, 1947.Google Scholar
  6. 6.
    S.Gard et L.Heller, Trois. Conf. Europ. de la Poliomyélite, Amsterdam-Leiden 1950.Google Scholar
  7. 7.
    C.Hallauer, Proc. Fourth Internat. Congress Microbiol. 257, 1947.Google Scholar
  8. 8.
    R. Schlesinger, Proc. Soc. exp. Biol. a. Med.74, 541, 1950.Google Scholar
  9. 9.
    J.van der Veen and J.Mulder, Onderz. Inst. v. Praev. Geneesk. No. 6, 1950.Google Scholar
  10. 10.
    J. D. Verlinde, P. de Baan, A. Kret andP. Waller-Fetter, Antonie van Leeuwenhoek17, 137, 1951.PubMedGoogle Scholar

Copyright information

© Swets en Zeitlinger 1951

Authors and Affiliations

  • J. D. Verlinde
    • 1
  • P. Waller-Fetter
    • 1
  • P. de Baan
    • 1
  1. 1.Department of Bacteriology and Experimental PathologyInstitute for Preventive MedicineLeiden

Personalised recommendations